Gene Therapy in Cardiovascular Disorder Market Size, Share, Analysis and Forecast to 2030
Gene Therapy in Cardiovascular Disorder market holds immense promise, with a valuation of US$ 178 million in 2023 and a projected exponential surge to US$ 1351.3 million by 2030, reflecting a remarkable CAGR of 21.1%. This burgeoning market represents a paradigm shift in addressing cardiovascular diseases by aiming to correct the root cause at the genetic level, offering potentially curative and long-lasting solutions